Rubfila International has scheduled its 33rd Annual General Meeting for September 29, 2026, to seek shareholder approval for the divestment of its wholly owned subsidiary, Premier Tissues India Limited. The company also intends to declare a final dividend of ₹2 per share.

The proposed transaction involves selling the entire 100% stake in Premier Tissues to Finquest Personal Care Pvt Ltd, a related party promoted by the company's Non-Executive Chairman, Hardik B Patel. The deal is valued at ₹61 crore, equivalent to ₹54.26 per equity share.

Strategic Divestment Details

The Board approved the transaction on August 20, 2026, noting that the offered consideration exceeds the valuations provided by two independent registered valuers. Ernst & Young Merchant Banking Services LLP valued the shares at ₹49.50 each, while Navigant Corporate Advisors Ltd placed the value at ₹47.93 each.

The carrying value of the investment in Premier Tissues as of June 30, 2026, was ₹32 crore. The divestment is expected to generate an estimated pre-tax gain of ₹29 crore and a net impact on profit of ₹24.85 crore after applicable taxes.

Financial Performance FY26

For the financial year ended March 31, 2026, Rubfila reported standalone revenue from operations of ₹51,171.86 lakh, an increase of approximately 9.24% from ₹46,840.78 lakh in the previous year. Standalone profit after tax rose to ₹2,630.13 lakh from ₹2,464.52 lakh.

On a consolidated basis, revenue grew to ₹60,249.96 lakh from ₹55,041.28 lakh. However, consolidated profit after tax declined to ₹2,661.19 lakh from ₹2,943.85 lakh in FY25. The decline in consolidated profit is attributed to lower profitability in the tissue paper segment, where segment results fell to ₹171.91 lakh from ₹642.10 lakh.

Auditor Qualification

Statutory auditors Mohan & Mohan Associates issued a qualified opinion on the standalone financial statements. The qualification relates to a provision for contingencies of ₹1,349 lakh accumulated over 11 years. The auditors stated that no present obligation arising from a past event was established, and the provision does not comply with Ind AS 37. The current year charge was ₹120 lakh.

What the Numbers Show

While standalone operations delivered consistent growth with revenue up 9.24% and PAT rising 6.72%, the consolidated bottom line contracted by roughly 9.6%. This divergence highlights the drag from the Premier Tissues subsidiary, which contributed significantly less to the group's bottom line despite generating ₹9,462.56 lakh in turnover. The proposed sale will remove this volatility from future consolidated results.

Meeting Logistics

The AGM will be held via video conference or other audio-visual means. Shareholders holding shares as of September 22, 2026, are eligible to vote. Remote e-voting will be available from September 26 to September 28, 2026.

Rubfila International reported a standalone net profit of ₹5.99 crore for the quarter ended June 30, 2026, a slight increase from ₹5.96 crore in the corresponding quarter of the previous fiscal year. However, the company’s standalone revenue from operations contracted by 10.8% to ₹11,143.57 lakh, compared to ₹12,486.11 lakh in Q1FY26.

On a consolidated basis, which includes its wholly owned subsidiary Premier Tissues India Limited, net profit declined 9.6% to ₹5.80 crore from ₹6.42 crore in the same period last year. Consolidated revenue from operations fell 17.1% to ₹13,491.49 lakh, down from ₹16,267.16 lakh in Q1FY26.

The Board of Directors approved the unaudited financial results in a meeting held on August 11, 2026. The auditors issued a modified opinion on the financial statements for the quarter.

Financial Performance

What the Numbers Show

Despite the decline in top-line revenue, Rubfila International managed to maintain near-flat profitability on a standalone basis. The pre-tax profit margin improved slightly to 7.2% in Q1FY27 (₹8.06 crore on ₹11,143.57 lakh revenue) compared to 6.4% in Q1FY26 (₹7.98 crore on ₹12,486.11 lakh revenue). This divergence between falling revenue and stable profits suggests either cost optimization or a shift in product mix toward higher-margin segments within its latex rubber thread and corrugated carton box businesses.

Balance Sheet and Regulatory Notes

The company’s debt-equity ratio remained low at 0.17 on a standalone basis and 0.20 on a consolidated basis as of June 30, 2026, indicating a conservative leverage profile. Net worth stood at ₹29,670.09 lakh (standalone) and ₹31,627.79 lakh (consolidated).

In its regulatory filing, the company noted that it has assessed the incremental financial impact of the new Labour Codes notified by the Government of India in November 2025. The Group reported no incremental charges in the standalone or consolidated financial results for the quarter, citing the non-recurring nature and immateriality of the impact based on current guidance from the Ministry of Labour & Employment and the Institute of Chartered Accountants of India.